Related Experiment Video
Updated: Jun 13, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
First Generation Tools for the Modeling of Capicua (CIC) - Family Fusion Oncoprotein-Driven Cancers
Cuyler Luck1,2, Kyle A Jacobs1,3, Julia Riad2,4
1Biomedical Sciences Graduate Program, University of California, San Francisco, CA, USA.
Synthetic gene fusions like CIC::NUTM1 and ATXN1::DUX4 reveal how CIC-rearrangements cause distinct cancers. These tools help study rare cancer subtypes by dissecting fusion oncoprotein activity.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Clinical presentation of CIC-rearrangement cancers varies, with CIC::DUX4 linked to soft tissue tumors and CIC::NUTM1 to CNS tumors.
- The molecular basis for these clinical differences is unclear due to limited research tools.
Purpose of the Study:
- To generate and validate synthetic coding sequences for CIC::NUTM1, CIC::LEUTX, and ATXN1::DUX4 fusions.
- To investigate the structure-function relationships of novel CIC-family fusion oncoproteins.
Main Methods:
- Generation of patient-informed synthetic coding sequences for specific CIC-family gene fusions.
- Structure-function studies to validate the synthetic sequences and analyze their biological activity.
Main Results:
- CIC::NUTM1 activates a distinct transcriptional program compared to CIC::DUX4, mediated by the NUTM1 C-terminal domain.
- CIC::LEUTX exhibits weak activation of CIC target genes via LEUTX transactivation sequences.
- ATXN1::DUX4 upregulates CIC target genes through the ATXN1 AXH domain.
Conclusions:
- The binding partner in CIC fusions significantly influences the oncoprotein's activity and downstream effects.
- Developed synthetic tools offer a novel resource for studying CIC-family fusions beyond CIC::DUX4.
- These tools enable detailed dissection of rare cancer subgroups driven by CIC-family gene rearrangements.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

